Contact
- Contact Us
- Submit a Press Release
- Submit a Coin
- Submit an Exchange
- Submit a Wallet
- Submit a Company
- Advertise
- Linktree
Molecules of Korolchuk IP-NFT, with ticker VITA-FAST, is a coin associated with VitaDAO, a community-owned collective funding early-stage longevity research. Governed by $VITA holders, VitaDAO aims to tackle aging by harnessing the power of a global community. Researchers can connect with an active community of longevity scientists and receive funding for their work. VitaDAO is built and owned by its community, and it encourages individuals to contribute their skills to advance longevity science.
VITA-FAST, the token associated with Molecules of Korolchuk IP-NFT, plays a crucial role in the governance of VitaDAO. This governance token empowers the community and enables active participation in decision-making processes. By holding VITA-FAST, community members can contribute to proposals, engage in discussions in the governance forum, and participate in treasury management. The VITA token is an essential component of VitaDAO’s community-driven approach, supporting the funding and advancement of longevity research.
Molecules of Korolchuk IP-NFT and its associated token, VITA-FAST, represent an opportunity for individuals to impact aging and longevity research positively. By participating in VitaDAO, community members can support researchers, connect with scientists, and contribute their skills to advance the field of longevity science. With a focus on funding early-stage projects and leveraging the global community’s power, VitaDAO aims to revolutionize healthcare and improve the quality of life for an aging population.
Stay in the loop. Subscribe for updates.
Are you looking to advertise? We offer press release publications, display banners, featured listings and more.
Contact us for questions, submit a PR or request our media kit.
Contact
Advertise
Are you looking to advertise? We offer press release publications, display banners, featured listings and more.
Contact us for questions, submit a PR or request our media kit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis